Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124570042 | 12457004 | 2 | F | 20120404 | 20160617 | 20160610 | 20160701 | EXP | GB-MHRA-EYC 00140033 | GB-ACTAVIS-2016-11489 | ACTAVIS | 36.00 | YR | M | Y | 73.00000 | KG | 20160701 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124570042 | 12457004 | 1 | PS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 600 MG, DAILY, MODIFIED RELEASE | UNCONFIRMED | 0 | 600 | MG | PATCH | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124570042 | 12457004 | 1 | Bipolar I disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124570042 | 12457004 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124570042 | 12457004 | Blood cholesterol increased | |
| 124570042 | 12457004 | Guttate psoriasis | |
| 124570042 | 12457004 | Pruritus | |
| 124570042 | 12457004 | Vitamin D decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124570042 | 12457004 | 1 | 20120201 | 0 |